Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human Serv”

1,157 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,157
Index total 30,257
Page 16 / 49

Quick answer

This filtered view shows 1,157 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,157 results for “The United States of America, as represented by the Secretary, Department of Health and Human Serv” · 30,257 patents in full index Clear search

  1. US 10849912

    Method of sensitizing cancer cells to the cytotoxic effects of apoptosis inducing ligands in cancer treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted

  2. US 10844387

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted

  3. US 10836721

    Thalidomide analogs and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  4. US 10837019

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  5. US 10837003

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  6. US 10836759

    Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  7. US 10835593

    Modified anthrax toxin protective antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  8. US 10829768

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  9. US 10829767

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  10. US 10829769

    Chimeric antigen receptors targeting b-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  11. US 10830678

    Photo-controlled removal of targets in vitro and in vivo

    The United States of America, as represented by the Secretary, Department of Health and Human Serv · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  12. US 10822588

    Agents and methods to elicit anti-tumor immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  13. US 10813952

    NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  14. US 10813993

    Display platform from bacterial spore coat proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  15. US 10815488

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  16. US 10815295

    Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  17. US 10815487

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  18. US 10815301

    Anti-CD30 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  19. US 10808011

    Recombinant HIV-1 envelope proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted

  20. US 10808010

    Peptide inhibitors of phosphoglycerate mutase and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted

  21. US 10799580

    Expression vector delivery system and use thereof for inducing an immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  22. US 10799584

    Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  23. US 10787419

    Cannabinoid receptor mediating iminopyrazole compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted

  24. US 10772849

    Methods of regulating cannabinoid receptor activity-related disorders and diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.